“Insulin-like growth factors and their binding proteins: biological actions”. Endocrine Reviews16 (1): 3–34. (February 1995). doi:10.1210/edrv-16-1-3. PMID7758431.
“Molecular and cellular aspects of the insulin-like growth factor I receptor”. Endocrine Reviews16 (2): 143–63. (April 1995). doi:10.1210/edrv-16-2-143. PMID7540132.
“Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis”. Biochimica et Biophysica Acta1836 (2): 345–53. (December 2013). doi:10.1016/j.bbcan.2013.10.005. PMID24189571.
“Insulin-like growth factor-1 receptor immunoreactive cells are selectively maintained in the paraventricular hypothalamus of calorically restricted mice”. International Journal of Developmental Neuroscience25 (1): 23–8. (February 2007). doi:10.1016/j.ijdevneu.2006.11.004. PMID17194562.
“Age-dependent loss of insulin-like growth factor-1 receptor immunoreactive cells in the supraoptic hypothalamus is reduced in calorically restricted mice”. International Journal of Developmental Neuroscience24 (7): 431–6. (November 2006). doi:10.1016/j.ijdevneu.2006.08.008. PMID17034982.
“Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model”. Cancer Research64 (23): 8620–9. (December 2004). doi:10.1158/0008-5472.CAN-04-2446. PMID15574769.
“RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility”. Oncogene25 (16): 2285–96. (April 2006). doi:10.1038/sj.onc.1209260. PMID16314838.
“Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer”. Veterinary and Comparative Oncology8 (4): 293–301. (December 2010). doi:10.1111/j.1476-5829.2009.00232.x. PMID21062411.
“C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor”. The Journal of Biological Chemistry274 (9): 5422–8. (February 1999). doi:10.1074/jbc.274.9.5422. PMID10026153.
“Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis”. Cancer Research68 (14): 5669–77. (July 2008). doi:10.1158/0008-5472.CAN-07-6364. PMID18632619.
“Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29”. The Journal of Biological Chemistry276 (35): 33054–60. (August 2001). doi:10.1074/jbc.M009913200. PMID11423532.
“Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10”. Molecular Endocrinology10 (6): 631–41. (June 1996). doi:10.1210/mend.10.6.8776723. PMID8776723.
“Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains”. The Journal of Biological Chemistry273 (12): 6860–7. (March 1998). doi:10.1074/jbc.273.12.6860. PMID9506989.
“Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system”. The Journal of Biological Chemistry270 (40): 23456–60. (October 1995). doi:10.1074/jbc.270.40.23456. PMID7559507.
“Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein”. The Journal of Biological Chemistry270 (32): 19151–7. (August 1995). doi:10.1074/jbc.270.32.19151. PMID7642582.
“Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor”. The Journal of Biological Chemistry273 (37): 24095–101. (September 1998). doi:10.1074/jbc.273.37.24095. PMID9727029.
“14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner”. The Journal of Biological Chemistry272 (17): 11663–9. (April 1997). doi:10.1074/jbc.272.17.11663. PMID9111084.
“Insulin-like growth factors and their binding proteins: biological actions”. Endocrine Reviews16 (1): 3–34. (February 1995). doi:10.1210/edrv-16-1-3. PMID7758431.
“Molecular and cellular aspects of the insulin-like growth factor I receptor”. Endocrine Reviews16 (2): 143–63. (April 1995). doi:10.1210/edrv-16-2-143. PMID7540132.
“Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis”. Biochimica et Biophysica Acta1836 (2): 345–53. (December 2013). doi:10.1016/j.bbcan.2013.10.005. PMID24189571.
“Insulin-like growth factor-1 receptor immunoreactive cells are selectively maintained in the paraventricular hypothalamus of calorically restricted mice”. International Journal of Developmental Neuroscience25 (1): 23–8. (February 2007). doi:10.1016/j.ijdevneu.2006.11.004. PMID17194562.
“Age-dependent loss of insulin-like growth factor-1 receptor immunoreactive cells in the supraoptic hypothalamus is reduced in calorically restricted mice”. International Journal of Developmental Neuroscience24 (7): 431–6. (November 2006). doi:10.1016/j.ijdevneu.2006.08.008. PMID17034982.
“Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease”. Cancer Research62 (10): 2942–50. (May 2002). PMID12019176.
“Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model”. Cancer Research64 (23): 8620–9. (December 2004). doi:10.1158/0008-5472.CAN-04-2446. PMID15574769.
“RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility”. Oncogene25 (16): 2285–96. (April 2006). doi:10.1038/sj.onc.1209260. PMID16314838.
“Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer”. Veterinary and Comparative Oncology8 (4): 293–301. (December 2010). doi:10.1111/j.1476-5829.2009.00232.x. PMID21062411.
“C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor”. The Journal of Biological Chemistry274 (9): 5422–8. (February 1999). doi:10.1074/jbc.274.9.5422. PMID10026153.
“Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis”. Cancer Research68 (14): 5669–77. (July 2008). doi:10.1158/0008-5472.CAN-07-6364. PMID18632619.
“Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29”. The Journal of Biological Chemistry276 (35): 33054–60. (August 2001). doi:10.1074/jbc.M009913200. PMID11423532.
“Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10”. Molecular Endocrinology10 (6): 631–41. (June 1996). doi:10.1210/mend.10.6.8776723. PMID8776723.
“Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains”. The Journal of Biological Chemistry273 (12): 6860–7. (March 1998). doi:10.1074/jbc.273.12.6860. PMID9506989.
“Grb10: A new substrate of the insulin-like growth factor I receptor”. Cancer Research56 (14): 3165–7. (July 1996). PMID8764099.
“Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system”. The Journal of Biological Chemistry270 (40): 23456–60. (October 1995). doi:10.1074/jbc.270.40.23456. PMID7559507.
“Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein”. The Journal of Biological Chemistry270 (32): 19151–7. (August 1995). doi:10.1074/jbc.270.32.19151. PMID7642582.
“Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor”. The Journal of Biological Chemistry273 (37): 24095–101. (September 1998). doi:10.1074/jbc.273.37.24095. PMID9727029.
“14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner”. The Journal of Biological Chemistry272 (17): 11663–9. (April 1997). doi:10.1074/jbc.272.17.11663. PMID9111084.